177 related articles for article (PubMed ID: 35887076)
21. Identification of novel target genes of nerve growth factor (NGF) in human mastocytoma cell line (HMC-1 (V560G c-Kit)) by transcriptome analysis.
Dutta P; Koch A; Breyer B; Schneider H; Dittrich-Breiholz O; Kracht M; Tamura T
BMC Genomics; 2011 Apr; 12():196. PubMed ID: 21501463
[TBL] [Abstract][Full Text] [Related]
22. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
23. Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo.
Li H; Wang Y; Chen Z; Lu J; Pan J; Yu Y; Zhao Y; Zhang H; Hu T; Liu Q; Yang J
Oncotarget; 2017 Jan; 8(4):5874-5884. PubMed ID: 27564113
[TBL] [Abstract][Full Text] [Related]
24. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
[TBL] [Abstract][Full Text] [Related]
25. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.
Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y
J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318
[TBL] [Abstract][Full Text] [Related]
26. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
27. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
Woo CW; Lucarelli E; Thiele CJ
Oncogene; 2004 Feb; 23(8):1522-30. PubMed ID: 14691455
[TBL] [Abstract][Full Text] [Related]
28. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
29. p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA.
Eggert A; Sieverts H; Ikegaki N; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):573-6. PubMed ID: 11107120
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell factor 1 inhibits proliferation and migration and induces apoptosis of neuroblastoma cells by inhibiting the ERK signaling pathway.
Luo G; Feng R; Sun Y; Zheng L; Wang Y; Chen Y; Wen T
Oncol Rep; 2019 Jan; 41(1):103-112. PubMed ID: 30365123
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion.
Li W; Cao J; Liu J; Chu W; Zhang C; Chen S; Kang Z
Cell Mol Biol Lett; 2019; 24():19. PubMed ID: 30891073
[TBL] [Abstract][Full Text] [Related]
32. Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.
Gryz EA; Meakin SO
Oncogene; 2003 Nov; 22(54):8774-85. PubMed ID: 14647472
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
[TBL] [Abstract][Full Text] [Related]
34. ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.
Li M; Sun C; Bu X; Que Y; Zhang L; Zhang Y; Zhang L; Lu S; Huang J; Zhu J; Wang J; Sun F; Zhang Y
Cell Death Dis; 2021 Jun; 12(6):620. PubMed ID: 34131100
[TBL] [Abstract][Full Text] [Related]
35. Calreticulin Regulates VEGF-A in Neuroblastoma Cells.
Weng WC; Lin KH; Wu PY; Lu YC; Weng YC; Wang BJ; Liao YF; Hsu WM; Lee WT; Lee H
Mol Neurobiol; 2015 Aug; 52(1):758-70. PubMed ID: 25288151
[TBL] [Abstract][Full Text] [Related]
36. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
[TBL] [Abstract][Full Text] [Related]
37. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
[TBL] [Abstract][Full Text] [Related]
38. [Receptor tyrosine kinase KIT may regulate expression of genes involved in spontaneous regression of neuroblastoma].
Lebedev TD; Spirin PV; Suntsova MV; Ivanova AV; Buzdin AA; Prokofjeva MM; Rubtsov PM; Prassolov VS
Mol Biol (Mosk); 2015; 49(6):1052-5. PubMed ID: 26710790
[TBL] [Abstract][Full Text] [Related]
39. 5'-Iodotubercidin represses
Chen C; Breslin MB; Guidry JJ; Lan MS
J Biol Chem; 2019 Apr; 294(14):5456-5465. PubMed ID: 30755485
[TBL] [Abstract][Full Text] [Related]
40. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
